bioAffinity Technologies, Inc.
BIAF
$0.245
$0.0062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.64% | 10.33% | -48.29% | 5.19% | -7.57% |
| Total Depreciation and Amortization | -26.78% | 0.65% | 1.52% | 0.13% | 1.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 290.20% | 39.51% | 26.06% | -35.12% | 0.88% |
| Change in Net Operating Assets | -95.18% | -40.42% | 2,086.78% | -132.29% | 117.20% |
| Cash from Operations | -61.24% | 2.11% | 1.87% | -11.54% | 34.68% |
| Capital Expenditure | 73.62% | -- | 100.00% | 66.78% | 31.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 73.62% | -- | 100.00% | 66.78% | 31.64% |
| Total Debt Issued | -- | -- | -137.00% | 29,200.00% | -103.25% |
| Total Debt Repaid | -19.97% | -52.97% | 0.00% | -0.66% | -1.92% |
| Issuance of Common Stock | 172.01% | -47.10% | 47.28% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Financing | 192.52% | -49.06% | 21.03% | 1,937.43% | -104.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 154.21% | -289.45% | 880.09% | 97.29% | -348.40% |